Chinese Elm Allergy Shots: The Fall Elm Misdiagnosed as Ragweed
Chinese elm (Ulmus parvifolia) is a Dutch-elm-disease-resistant Asian ornamental planted widely across Gulf Coast, Pacific, and lower Mississippi cities — and it pollinates August–November, not in spring. Patients with fall rhinoconjunctivitis are typically worked up for ragweed and mold while the Chinese elm overhead goes undiagnosed. No IUIS-named allergen exists and no SCIT RCT has been published for this species.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Chinese Elmis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Chinese Elm Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to chinese elm — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of chinese elm allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of chinese elm immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of chinese elm extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for chinese elm allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing chinese elm extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription chinese elm immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat chinese elm allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Chinese Elm?
The biology, taxonomy, and clinical fingerprint of Chinese Elm — the foundation of how SCIT targets it.
Chinese elm (lacebark elm) is planted throughout US cities as a Dutch-elm-disease-resistant ornamental; it releases pollen in fall rather than spring, making it the most commonly missed urban fall tree allergen.
- Scientific name
- Ulmus parvifolia
- Family
- UlmaceaeElm family
- Type
- Tree pollen — wind-pollinated, fall-shedding deciduous ornamental
- Native to
- Eastern Asia; widely naturalized as US urban ornamental
- Allergen proteins
- No formally named IUIS allergen for Ulmus parvifolia as of May 2026
- Particle size
- 23–38 µm equatorial diameter, oblate, stephanoporate (5–6 pores)
- Avoidance difficulty
- Very difficult
How Chinese Elm Allergy Presents
Symptoms by body system — useful for distinguishing Chinese Elm sensitivity from overlapping allergies and infections.
Respiratory
- Sneezing attacks and rhinorrhea beginning in late August or September
- Nasal congestion persisting through October and into November
- Post-nasal drip and overnight cough during the fall elm pollen window
- Worsening allergic asthma coinciding with high fall Chinese elm pollen counts
- Symptoms persisting after ragweed antihistamine treatment without improvement
Ocular
- Watery, itchy eyes during August–November Chinese elm pollen season
- Conjunctival redness and periorbital swelling during high-count fall days
- Contact lens intolerance during fall elm pollen season
- Eye symptoms that coincide with but outlast the ragweed peak
Dermal
- Atopic dermatitis flares coinciding with fall elm pollen season
- Facial flushing and periorbital swelling in highly sensitized patients
- Contact urticaria from handling freshly cut lacebark elm branches (rare)
Systemic
- Fatigue and reduced concentration during the prolonged fall elm pollen window
- Sleep disruption from fall-onset nasal congestion
- Generalized malaise in patients with concurrent fall sensitizations to Chinese elm, ragweed, and mold
- Headache from sustained sinus congestion during the September–October peak
If your fall rhinitis isn't responding to antihistamines that reliably crush ragweed, look up. The lacebark elm you've been walking past for years probably came from a 1990s urban-replanting program — and it's shedding pollen in September, not March.
When & Where Chinese Elm Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: September–October — a fall pollination season opposite to the textbook February–April spring elm window· ~10–12 weeks of active pollen season; Anderegg et al. (PNAS 2021) document fall seasons lengthening across the US
US Exposure Map
8 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- Moderate
- MT:
- Low
- ND:
- Low
- MN:
- Low
- WI:
- Low
- MI:
- Low
- NY:
- Low
- MA:
- Low
- OR:
- Moderate
- ID:
- Low
- WY:
- Low
- SD:
- Low
- IA:
- Low
- IL:
- Low
- IN:
- Low
- OH:
- Low
- PA:
- Low
- NJ:
- Low
- CT:
- Low
- RI:
- Low
- CA:
- High
- NV:
- Moderate
- UT:
- Low
- CO:
- Low
- NE:
- Low
- MO:
- Low
- KY:
- None
- WV:
- Low
- VA:
- Low
- MD:
- Low
- DE:
- Low
- AZ:
- High
- NM:
- Moderate
- KS:
- Low
- AR:
- Moderate
- TN:
- Moderate
- NC:
- Moderate
- SC:
- Moderate
- OK:
- Moderate
- LA:
- High
- MS:
- High
- AL:
- High
- GA:
- High
- TX:
- High
- FL:
- High
- AK:
- Low
- HI:
- Low
What Chinese Elm Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Chinese elm cross-reactivity is contained within the Ulmaceae family; studies show little cross-reactivity between elm species and Fagales, Oleaceae, or other major tree families (Lewis & Vinay).
Is SCIT Right for Your Chinese Elm Allergy?
Answer five questions to assess whether Chinese elm SCIT fits your fall rhinitis profile.
How severe are your fall (August–November) allergy symptoms?
The Chinese Elm SCIT Protocol
Chinese elm SCIT uses a non-standardized extract with the build-up schedule calibrated individually; optimal timing targets completing build-up before the August–September fall elm season.
Starting in winter or early spring, the allergist escalates from very dilute elm extract to the target maintenance dose over 6–8 months, completing build-up before the August–September Chinese elm pollen onset. The 30-minute post-injection observation period is mandatory at every visit.
Ongoing maintenance injections continue through the fall pollen season, providing ongoing immunologic protection during peak Chinese elm exposure in September–October. The 30-minute post-injection observation period is required at each maintenance visit.
After completing the recommended course, durable symptom relief is the goal — most patients maintain benefit for multiple fall seasons after stopping immunotherapy.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Chinese Elm SCIT
No randomized controlled trial has been published for Chinese elm SCIT. Clinical evidence is extrapolated from Ulmaceae family-level observations and the broader non-standardized tree SCIT evidence base.
- Ulmus pollen–asthma hospitalization association55%Dales et al., Int Arch Allergy Immunol 2008;146:241–247 — Canadian cities multi-species pollen study
- Elm sensitization prevalence in US allergic patients25%Hoffman, cited in Ann Allergy Asthma Immunol 2014 Chinese Elm allergen-of-the-month review; 371-patient US series
- Estimated benefit from non-standardized tree SCIT (extrapolated framework)48%Cox L et al., J Allergy Clin Immunol 2011;127:S1–S55 — Practice Parameter Third Update
Chinese elm SCIT has no dedicated efficacy trial. The Ann Allergy Asthma Immunol 2014 allergen-of-the-month review highlights the clinical importance of fall-pollinating Ulmus parvifolia and the diagnostic gaps it creates. Clinical prescribing follows the AAAAI/ACAAI Practice Parameter for confirmed sensitization with inadequate pharmacotherapy response.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Chinese Elm SCIT Side Effects
Chinese elm SCIT side effects are consistent with non-standardized inhalant tree extract immunotherapy; local reactions are common and serious systemic events are rare.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site erythema and swelling Most common local reaction; typically resolves within a few hours | Rate 25–50% | Mild |
Injection-site pruritus Localized itching; cold compress relieves most cases | Rate 20–35% | Mild |
Large local reaction Swelling >5 cm; may require dose adjustment before next injection | Rate 5–10% | Moderate |
Delayed local soreness Induration appearing 4–8 hours post-injection; usually self-limited | Rate 5–8% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Rhinitis or conjunctivitis flare Transient nasal or eye symptom exacerbation; resolves spontaneously | Rate 0.5–1% | Mild |
Urticaria Hives beyond injection site; requires clinical evaluation and possible dose adjustment | Rate 0.1–0.3% | Moderate |
Mild bronchospasm Underlying asthma is a risk factor requiring pre-injection assessment; bronchospasm is managed promptly, and Curex confirms a prescribed epinephrine auto-injector is on hand with the first injection from each new vial or concentration supervised live in the Virtual Shot Room. | Rate 0.1–0.2% | Moderate |
Anaphylaxis Extremely rare; a 30-minute self-observation, a prescribed epinephrine auto-injector confirmed on hand, and live Zoom supervision of the first injection from each new vial or concentration is designed to detect and manage it immediately. | Rate <0.01% | Severe |
SCIT has traditionally been given in a clinic with emergency equipment; for eligible patients, Curex makes safe at-home self-administration possible with a personalized serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first injection from each new vial or concentration supervised live in the Virtual Shot Room. A 30-minute observation follows every dose and remains a core safety step that should not be shortened.
SCIT vs Alternatives for Chinese Elm
Fall allergy management for Chinese elm-sensitized patients spans targeted pharmacotherapy, avoidance (limited for urban tree pollen), sublingual immunotherapy, and SCIT — now available as a weekly at-home shot with Curex.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Moderate (no RCT) | Comparable (extrapolated) | Partial only | Good short-term control |
| 5-yr cost | $3,500–$9,000 | Varies by provider; offered as a general modality, not by Curex | Low | $500–$2,000/yr |
| Duration | 3–5 years | 3–5 years | Ongoing | Lifelong |
| Convenience | Weekly at-home build-up easing to ongoing maintenance with Curex | Daily drops at home | Very difficult outdoors | Daily pill/spray |
| Safety | Very safe; sterile-compounded serum plus live Zoom supervision of every dose change | Very safe | Excellent | Generally safe |
| Lasting effect | Yes, years post-tx | Yes, years post-tx | No | No — returns off meds |
SCITBest
SLIT
Avoidance
Medications
For confirmed Chinese elm sensitization with multi-season fall symptoms, SCIT offers the most durable long-term benefit — and with Curex, eligible patients self-administer that shot at home with pricing confirmed in a current program quote instead of attending weekly clinic visits, with the first injection from each new vial or concentration supervised live in the Virtual Shot Room and a prescribed epinephrine auto-injector confirmed on hand.
What Chinese Elm SCIT Actually Costs
Most major US insurers cover Chinese elm SCIT under standard allergy benefits when prescribed by a board-certified allergist with documented positive Chinese elm sensitization; prior authorization is typically required, and patient out-of-pocket costs vary with deductible and co-insurance. Curex at-home IgE testing identifies specific chinese elm sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your chinese elm allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Chinese Elm SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Most people assume all elms pollinate in spring like American elm (February–April), but Chinese elm (Ulmus parvifolia) is botanically different — it sheds pollen August through November, peaking in September and October. This timing is the opposite of most temperate-zone trees and is why Chinese elm is so frequently missed as a fall allergen. It was planted widely across Gulf Coast, California, and lower Mississippi cities as a Dutch-elm-disease-resistant replacement for American elm starting in the 1970s and 1980s. Patients living under these trees experience genuine tree-pollen rhinitis during a season when clinicians are focused on ragweed and mold. A fall-season IgE panel that includes Ulmus parvifolia specifically can confirm whether this is the missed driver of your symptoms.
Ragweed peaks from mid-August through September in most of the Eastern and Midwest US, while Chinese elm extends from August through November and is most prominent in the Gulf, Pacific, and Southern states. Several clues point toward Chinese elm: symptoms that continue well into October and November after ragweed counts drop; geographic location in a city with heavy urban ornamental plantings; and fall symptoms that do not adequately respond to antihistamines that normally suppress ragweed reactions. Definitive distinction requires allergen-specific IgE testing to both Ambrosia (ragweed) and Ulmus parvifolia (Chinese elm). A board-certified allergist can order both and interpret the results in the context of your symptom timing.
Chinese elm has naturalized across most of the southern and western US, with the highest urban density in California, Arizona, Texas, Louisiana, Mississippi, Alabama, Georgia, and Florida. It is sold under the name 'lacebark elm' at nurseries and is a common street tree in cities that replanted after Dutch elm disease. In Pacific Northwest cities (Portland, Seattle) it appears in residential neighborhoods. Even in cities without official planting programs, Chinese elm has naturalized from cultivated stock and appears in parks, roadsides, and disturbed urban edges. The USDA Plants Database documents its naturalized distribution. If you live in a Gulf Coast, southern California, or desert Southwest city and have fall outdoor rhinitis, Chinese elm should be on your differential.
Most patients notice meaningful improvement in fall elm symptoms after 1–2 completed fall pollen seasons on the maintenance dose — typically 12–24 months into treatment. The build-up phase (6–8 months) itself may provide partial benefit during the first Chinese elm season if timing aligns, but the full immunologic response develops more gradually. Because no published RCT specifically tracks Chinese elm SCIT outcomes, these timelines are extrapolated from the broader Ulmaceae SCIT literature and the AAAAI/ACAAI Practice Parameter (Cox 2011). Consistent adherence to the injection schedule is the key driver of how quickly and completely symptoms improve.
Yes — multi-allergen SCIT including both Chinese elm and ragweed in the same or separate vials is standard practice for patients with multiple documented sensitizations. Because fall Chinese elm and fall ragweed seasons overlap substantially, a patient sensitized to both benefits from addressing both allergens. Your allergist will review whether combining them in a single vial or keeping them separate (to avoid interference between the extracts) is appropriate for your specific panel. The AAAAI/ACAAI Practice Parameter (Greenhawt 2023) supports multi-allergen mixes for confirmed sensitizations, with concentration adjustments when combining multiple extracts.
Elm pollen has been associated with increased asthma hospitalization rates (Dales et al., Int Arch Allergy Immunol 2008), and allergen immunotherapy is supported for mild-to-moderate allergic asthma when the sensitizing allergen is confirmed. If your fall asthma exacerbations correlate with the September–November Chinese elm pollen window and IgE testing confirms U. parvifolia sensitization, SCIT targeting Chinese elm may reduce both nasal and bronchial symptom burden. Asthma must be adequately controlled (FEV1 ≥70% predicted) before starting or continuing SCIT, and baseline spirometry or peak flow should be assessed before each injection.
Both Chinese elm (Ulmus parvifolia) and cedar elm (Ulmus crassifolia) are fall-pollinating elms, but they differ in origin and distribution. Chinese elm is an Asian ornamental planted widely in urban landscapes across the US for Dutch-elm-disease resistance; it is most prevalent in Gulf Coast, Pacific Coast, and lower Mississippi cities. Cedar elm is a native Texas-Oklahoma-Louisiana species dominant in wild woodland habitats across north Texas, shedding pollen August–November in the same window. Both have strong intra-Ulmaceae cross-reactivity, but Chinese elm sensitization is more likely in patients in cities, while cedar elm sensitization is typical for patients near native woodlands in central Texas. Species-specific IgE testing distinguishes them, and prescribing the right species improves the precision of the extract.
Most major US health insurers cover Chinese elm SCIT under standard allergy benefits when ordered by a board-certified allergist with documented positive sensitization testing (skin-prick or specific IgE to Ulmus parvifolia). A fall-season allergic rhinitis diagnosis code and a clear symptom history are typically required for coverage approval. Out-of-pocket costs over a 5-year course generally range from $3,500 to $9,000 depending on plan deductible and co-insurance. Prior authorization is commonly required; your allergist's billing office can assist with the authorization process and appeal if initial approval is denied.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.